Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Lilly Says Thimerosal Provision Is Clarification Of Existing Law, Not Change

Executive Summary

Thimerosal liability protection included in the Homeland Security legislation is a clarification of existing law rather than a change, Lilly says

You may also be interested in...



Rep. Burton gets subcommittee chair

Former House Government Reform Committee Chair Dan Burton (R-Ind.) named to oversee newly created Subcommittee on Wellness & Human Rights. Subcommittee will address issues concerning public health policy, human rights and family health - providing Burton with a platform to continue his investigation of vaccine safety (1"The Pink Sheet" Dec. 16, 2002, p. 18)...

Rep. Burton gets subcommittee chair

Former House Government Reform Committee Chair Dan Burton (R-Ind.) named to oversee newly created Subcommittee on Wellness & Human Rights. Subcommittee will address issues concerning public health policy, human rights and family health - providing Burton with a platform to continue his investigation of vaccine safety (1"The Pink Sheet" Dec. 16, 2002, p. 18)...

House Committee Assignments: Little Shake-Up In The New Make-Up

Members of the House Energy & Commerce and Ways & Means Committees in the 108th Congress are likely to stay the course set by their predecessors regarding prescription drug issues

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040951

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel